http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108495844-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
filingDate 2017-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc644046fd8d2182cb4e7b012ce066a
publicationDate 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108495844-A
titleOfInvention Crystalline Erracycline Dihydrochloride
abstract The present invention relates to crystalline Erlacycline dihydrochloride and a process for its preparation. Furthermore, the present invention relates to the use of crystalline Erracycline dihydrochloride for the preparation of pharmaceutical compositions. The present invention further relates to pharmaceutical compositions comprising an effective amount of crystalline Erracycline dihydrochloride. The pharmaceutical composition according to the invention can be used as a medicament, in particular for the treatment and/or prophylaxis of bacterial infections, e.g. caused by Gram-negative pathogens or Gram-positive pathogens, in particular caused by multi-drug resistant Gram-negative pathogens Medicines for bacterial infections. Accordingly, the pharmaceutical composition of the present invention can be used as a medicament for eg treating complicated intra-abdominal and urinary tract infections.
priorityDate 2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102459153-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012021829-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10954115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54726192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574955

Total number of triples: 32.